Risk Factors for Drug-Resistant Tuberculosis

Home > Journals > Biomedical & Life Sciences | Medicine & Healthcare >JTR

ISSN Print: 2329-843X
ISSN Online: 2329-8448

Website: https://www.scirp.org/journal/jtr
E-mail: jtr@scirp.org

Citations h5-index & Ranking*

Submission

"Risk Factors for Drug-Resistant Tuberculosis"
written by Marta Gomes, Ana Correia, Denisa Mendonça, Raquel Duarte,
published by Journal of Tuberculosis Research, Vol.2 No.3, 2014

has been cited by the following article(s):

Google Scholar
CrossRef

[1]	DETERMINATION OF MAJOR FACTORS PREDICTING MDRTB AMONG PRESUMPTIVE MDRTB CASES IN PLATEAU STATE–NIGERIA
	2020

[2]	Analysis of drug susceptibility patterns in tuberculosis diagnosed cases from Ecuador during 2012-2017
	2020

[3]	Increasing Burden of Multidrug Resistant Tuberculosis in HIV Infected Individuals: A Systematic Review and Meta-Analysis
	2020

[4]	RISK FACTORS FOR MULTI DRUG-RESISTANT TUBERCULOSIS AMONG TUBERCULOSIS PATIENTS OF NEKEMTE REFERRAL HOSPITAL, OROMIA REGIONAL STATE, WESTERN ETHIOPIA
	Scientific Research and Reviews, 2019

[5]	Treatment outcomes of patients with MDR-TB and its determinants at referral hospitals in Ethiopia
	Thesis, 2019

[6]	Karakteristike toka plućne tuberkuloze kod obolelih od šećerne bolesti
	2019

[7]	Penanganan Tuberkulosis Resistan Obat pada Daerah Terpencil: Mission Impossible?
	2019

[8]	RISK FACTORS FOR MULTI DR TUBERCULOSIS PATIENTS OF N REGIONAL STATE
	2019

[9]	Association between DOTS program and the outcome of previous therapy in MDR-TB patients: a case study in Tasikmalaya district, West Java, Indonesia
	2019

[10]	Determinants of Multi-Drug Resistant Tuberculosis among Tuberculosis Patients in Southern Ethiopia: A Case Control Study
	2019

[11]	Treatment outcomes of drug resistant tuberculosis patients in Morocco: multi-centric prospective study
	2019

[12]	Drug resistance profile of Mycobacterium tuberculosis and predictors associated with the development of drug resistance
	2019

[13]	Factors associated with isoniazid resistant tuberculosis among human immunodeficiency virus positive patients in Swaziland: a case-control study
	2019

[14]	First-line tuberculosis drug resistance patterns and associated risk factors in Germany, 2008-2017
	2019

[15]	Clinical Risk Factors Associated with Multidrug-Resistant Tuberculosis (MDR-TB) in Mali
	2019

[16]	Drug resistant tuberculosis in Saudi Arabia: an analysis of surveillance data 2014–2015
	2018

[17]	Kejadian Tuberkulosis Multi Drug Resistant di RSUP dr. Kariadi
	2018

[18]	ASSOCIATION OF MULTIDRUG RESISTANT PULMONARY TUBERCULOSIS AND DIABETES MELLITUS
	2018

[19]	Antituberculosis-drug resistance in the border of Brazil with Paraguay and Bolivia/Resistencia as drogas antituberculose na fronteira do Brasil com Paraguai e Bolivia
	Revista Panamericana de Salud Publica, 2017

[20]	Structural analysis of the mycobacterium tuberculosis redox defence network reveals a unique bi-fan motif design associated with hydrogen peroxide reduction.
	2017

[21]	Resistência às drogas antituberculose na fronteira do Brasil com Paraguai e Bolívia
	2017

[22]	Synergies between Communicable and Noncommunicable Disease Programs to Enhance Global Health Security
	Emerging infectious diseases, 2017

[23]	Assess drug resistance pattern and genetic profile of Mycobacterium tuberculosis clinical isolates by molecular typing methods using direct repeats and IS6110 in pulmonary tuberculosis cases
	Lung India, 2017

[24]	Antituberculosis-drug resistance in the border of Brazil with Paraguay and Bolivia
	Resistência às drogas , 2017

[25]	Factors associated with mortality to drug-resistant tuberculosis and their programmatic management in treatment centres of Punjab, Pakistan.
	2017

[26]	Gambaran Karakteristik Pasien TB-MDR Dengan Diabetes Melitus di Rumah Sakit Umum Pusat Haji Adam Malik Medan Tahun 2016
	2017

[27]	TO EVALUATE PREVALENCE OF DIABETES AND HIV IN NEWLY-DIAGNOSED MULTIDRUG-RESISTANT TUBERCULOSIS PATIENTS ADMITTED FOR PRETREATMENT EVALUATION IN DOTS PLUS CENTRE, THANJAVUR
	J. Evid. Based Med. Healthc., 2017

[28]	Factors associated with mortality to drug-resistant tuberculosis and their programmatic management in treatment centres of Punjab, Pakistan
	2017

[29]	Predictors of multidrug resistant tuberculosis among adult patients at Saint Peter Hospital Addis Ababa, Ethiopia
	2016

[30]	Pattern of prevalence, risk factors and treatment outcomes among Egyptian patients with multidrug resistant tuberculosis
	Egyptian Journal of Chest Diseases and Tuberculosis, 2016

[31]	ارزیابی عوامل مرتبط بر منفی شدن اسمیر خلط بیماران سل ریوی در پایان ماه دوم درمان‎
	2016

[32]	Pattern of Drug Resistance and Risk Factors Associated with Development of Drug Resistant Mycobacterium tuberculosis in Pakistan
	PloS one, 2016

[33]	Evaluating related factors with sputum smear negation at the end of the second month of tuberculosis treatment
	2016

[34]	Prevalence and Genetic Variation among Drug Resistance Genes of Mycobacterium tuberculosis
	2015

[35]	RISK FACTORS FOR MULTI DRUG-RESISTANT TUBERCULOSIS AMONG TUBERCULOSIS PATIENTS OF NEKEMTE REFERRAL HOSPITAL, OROMIA …


[36]	TO EVALUATE PREVALENCE OF DIABETES AND HIV IN NEWLY-DIAGNOSED MULTIDRUG-RESISTANT TUBERCULOSIS PATIENTS ADMITTED FOR …

[1]	Clinical risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in Mali International Journal of Infectious Diseases, 2019 DOI:10.1016/j.ijid.2019.02.004

[2]	Drug resistance profile of Mycobacterium tuberculosis and predictors associated with the development of drug resistance Journal of Global Antimicrobial Resistance, 2019 DOI:10.1016/j.jgar.2019.03.009

[3]	Treatment outcomes of drug resistant tuberculosis patients in Morocco: multi-centric prospective study BMC Infectious Diseases, 2019 DOI:10.1186/s12879-019-3931-5

[4]	First-line tuberculosis drug resistance patterns and associated risk factors in Germany, 2008-2017 PLOS ONE, 2019 DOI:10.1371/journal.pone.0217597

[5]	Factors associated with isoniazid resistant tuberculosis among human immunodeficiency virus positive patients in Swaziland: a case-control study BMC Infectious Diseases, 2019 DOI:10.1186/s12879-019-4384-6

[6]	ASSOCIATION OF MULTIDRUG RESISTANT PULMONARY TUBERCULOSIS AND DIABETES MELLITUS Journal of Evolution of Medical and Dental Sciences, 2018 DOI:10.14260/jemds/2018/617

[7]	TO EVALUATE PREVALENCE OF DIABETES AND HIV IN NEWLY-DIAGNOSED MULTIDRUGRESISTANT TUBERCULOSIS PATIENTS ADMITTED FOR PRETREATMENT EVALUATION IN DOTS PLUS CENTRE, THANJAVUR Journal of Evidence Based Medicine and Healthcare, 2017 DOI:10.18410/jebmh/2017/721

[8]	Pattern of prevalence, risk factors and treatment outcomes among Egyptian patients with multidrug resistant tuberculosis Egyptian Journal of Chest Diseases and Tuberculosis, 2017 DOI:10.1016/j.ejcdt.2016.11.002

[9]	Synergies between Communicable and Noncommunicable Disease Programs to Enhance Global Health Security Emerging Infectious Diseases, 2017 DOI:10.3201/eid2313.170581

[10]	Resistência às drogas antituberculose na fronteira do Brasil com Paraguai e Bolívia Revista Panamericana de Salud Pública, 2017 DOI:10.26633/RPSP.2017.9

[11]	Pattern of Drug Resistance and Risk Factors Associated with Development of Drug Resistant Mycobacterium tuberculosis in Pakistan PLOS ONE, 2016 DOI:10.1371/journal.pone.0147529